Future of diagnostics to be co-created by public and private sector
Diagnosis of disease has been going digital in recent years. So has training of staff. Now, the Copenhagen Science City-partner University hospital Rigshospitalet has entered an agreement with health and care-giant Roche Diagnostics to co-create, develop and test future digital diagnostic solutions and digital further training of staff.
Innovation to improve patients’ lives
Roche Diagnostics is one of the world’s largest diagnostic companies. University hospital Rigshospitalet recently established an Innovation Centre with an ambition to be a global spearhead for the development of future health solutions. The centre aims to collaborate with companies that bring relevant knowledge and technological solutions to the table, explains Rigshospitalet’s director Per Christiansen.
Together with external actors, we must create innovation that improves patients’ lives. It is our ambition to create an overall innovation effort across the highly specialized departments at Rigshospitalet. Great results are only achieved when we reach out and let others be part of the equation, so we also invite interest groups, municipalities and regions to get involved in the work”: Per Christiansen, CEO, Rigshospitalet
Innovation in an authentic environment
Per Christiansen emphasizes that the complexity of the health challenges of the future is so high that Rigshospitalet cannot solve them alone. For CEO Tim Himes at Roche Diagnostics, the collaboration agreement with Rigshospitalet is an opportunity to test new solutions in a hospital environment.
The speed at which new digital tools and technologies become available is increasing. Innovation comes from many sides. The big challenge is how to evaluate and test these innovations in a suitable and authentic environment. Our partners at Rigshospitalet see some of the same challenges. Together we hope to develop completely new, innovative solutions, and validate them at the most specialized hospital in Denmark”: Tim Himes, CEO, Roche Diagnostics
Wish to be world leaders in digital diagnostics
Diagnostics are undergoing a massive transformation. Increased use of data, digital solutions and digital competencies for healthcare professionals unlocks great potential for faster and better treatment of patients. Rigshospitalet’s head of innovation, Henning Langberg, says that the hospital has several current and future needs that technology must help solve. This was the starting point for the collaboration with Roche Diagnostics.
Together we can develop a leading platform for innovation and testing of new technologies in the field of digital diagnostics. We want to contribute to the digitalisation that plays an ever-bigger part in maintaining a sustainable healthcare system. Roche Diagnostics can help accelerate that development”: Henning Langberg, head of innovation, Rigshospitalet.
Rigshospitalet invites more co-creators
The collaboration agreement between Rigshospitalet and Roche Diagnostics is a non-exclusive framework agreement. This means that Rigshospitalet is open to collaboration with all companies that have competencies, technology or other resources that can support the needs of the hospital.
It is very important to emphasize, that the collaboration agreement between Roche Diagnostics and Rigshospitalet is a non-exclusive agreement. As a public hospital, we do not commit to regular collaborations with one specific partner. Instead, we invite everyone who wants to- and can contribute to better patient care- to take part in innovation at the hospital”: Henning Langberg innovation manager, Rigshospitalet.